Thrivent Financial for Lutherans Sells 272,660 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Thrivent Financial for Lutherans lessened its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 30.7% in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 614,365 shares of the exchange traded fund’s stock after selling 272,660 shares during the period. Thrivent Financial for Lutherans owned about 0.81% of SPDR S&P Biotech ETF worth $56,958,000 at the end of the most recent reporting period.

Several other hedge funds have also made changes to their positions in XBI. Corient Private Wealth LLC lifted its stake in SPDR S&P Biotech ETF by 22.2% during the fourth quarter. Corient Private Wealth LLC now owns 126,177 shares of the exchange traded fund’s stock worth $11,266,000 after purchasing an additional 22,902 shares during the period. Trexquant Investment LP bought a new position in SPDR S&P Biotech ETF during the fourth quarter worth about $278,000. Johnson Financial Group Inc. bought a new position in SPDR S&P Biotech ETF during the fourth quarter worth about $262,000. Parallel Advisors LLC lifted its stake in SPDR S&P Biotech ETF by 2.2% during the fourth quarter. Parallel Advisors LLC now owns 41,983 shares of the exchange traded fund’s stock worth $3,749,000 after purchasing an additional 886 shares during the period. Finally, Mitchell Sinkler & Starr PA bought a new position in SPDR S&P Biotech ETF during the fourth quarter worth about $672,000.

SPDR S&P Biotech ETF Trading Down 0.8 %

NYSEARCA XBI opened at $101.61 on Monday. The firm has a market cap of $7.74 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11. The company has a 50 day moving average of $99.03 and a 200-day moving average of $93.90. SPDR S&P Biotech ETF has a 1-year low of $63.80 and a 1-year high of $103.52.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.